DIVERSE EFFECTS OF INDOLOCARBAZOLE COMPOUNDS ON THE CELL CYCLE PROGRESSION
OF r^-TRANSFORMED RAT FIBROBLAST CELLS Shiro Akinaga*, Kayo Nomura, Katsushige Gomi and Masami Okabe Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shimotogari 1 188, Nagaizumi-cho, Sunto-gun, Shizuoka 41 1, Japan (Received for publication June 7, 1993) Indolocarbazole compounds have been reported to exert antitumor activity against human and murine tumor cell lines in vitro and/or in v/vo1~13).
These compoundsare thought to be divided into two major groups, i.e. protein kinase inhibitors and topoisomerase inhibitors7). The former includes natural compounds such as staurosporine1}, K252a2) and UCN-013~5) as well as chemically synthesized derivatives of the natural compounds2'6'1 1}.
The latter includes natural compounds such as rebeccamycin8), AT24339) and several derivatives of the natural compounds which did not exert the apparent inhibitory activities against protein kinases7'10~12).
Recent studies showed that staurosporine and K-252a exhibited a unique effect on the cell cycle distribution of mammalian cells13~17). At lower concentrations, for example, they induced a Gl (or Gl/S) phase accumulation in the cell cycle in a reversible manner, however, at higher concentrations, they exhibited a block of the cell cycle at G2M phase13~17). In addition, staurosporine16) and/or K-252a15) induced a higher DNAploidy in some types of cells. However, at least to our knowledge, there have been few studies comparing the cell cycle effects of indojocarbazole compoundsin relation to their different biological effects.
In this study, we compared the effects of non-selective protein kinase inhibitors (staurosporine1'^and K-252a2'7)), protein kinase C (PKC) selective inhibitors (UCN-013~5) and CGP 41 2516)), and topoisomerase I inhibitors (the derivatives of K-252a, KT6124, KT6006 and KT652812)) on the cell cycle distribution of ras-transformed rat 3Y1 cells, HR-3Y115'18). This cell line was selected for this study because 1) it was reported that K-252a had induced DNAhigher ploidy in this cell line more effectively than in other cell lines15) and 2) it was suggested that nzs-activated tumor cell lines might be a target for PKCinhibitors such as UCN-015). The chemical structures of all the compounds used in this study are shown in Fig. 1 . The inhibitory activities of these indolocarbazole Exponentially growing HR-3Y1cells were treated with the drugs at the indicated concentrations for 24 hours, and the cell cycle distribution was determined from DNAhistograms in Fig. 1 by the MULTICYCLE program.
Cell growth inhibition of each drug was determined by MTTmethod.
compounds against PKC, protein kinase A (PKA) and topoisomerase I are summarized in Table 1 . To compare the cell cycle effects of all the indolocarbazole compounds used in this study under the same condition, the flow cytometric analysis was performed after 24 hours exposure of the cells to the drugs under the cytostatic conditions as shown in Table 2 ). However, KT6006 induced not only the S phase delay but also G2Mphase block with a small population of higher DNAploidy as shown in Fig. 2H and Table 2 . These results show that seven indolocarbazole compoundswith minor stuructural differences were found to cause quite different effects on the cell cycle progression of ras-transformed rat fibroblast cells .
The effects of these compounds on the cell cycle distribution are classified into the following four groups. The first group consists of staurosporine, K-252a and CGP41 251 that cause the G2M phase block and the higher DNAploidy, which was reported previously for staurosporine16) and K-252a1 5). These effects were thought to be mediated through, at least in part, the inhibition of cdc2 kinase15'19) which was supposed to play a central role in the transition of the G2 to M phase in the cell cycle progression20). The second type represented by UCN-01is the preferential induction of the Gl phase block (Fig.   2B ), although this compound selectively inhibits PKC as does CGP 41 251. A similar pattern of Gl phase accumulation was also detected when the cells were treated with lower concentrations of staurosporine and K-252a13~16) (data not shown),
suggesting that the inhibition of serine/threonine kinases including PKCmight play an important role in the induction of the Gl phase block. In addition, the inhibition of cdk2 kinase might be important for the induction of the Gl phase accumulation by these compounds, because cdk2 is supposed to play an important role in the Gl to S phase transition in cell cycle progression20). A possible inhibition of cdk2 kinase by these compoundsremains to be determined. The third type is the induction of S phase delay represented by KT6124 and KT6528 (Figs. 2F and 2G) . This effect was never detected in the cells treated with staurosporine, K-252a, CGP 41 251 and UCN-01. The pattern of cell cycle effect is similar to that of camptothecin ( Fig. 21 and ref 21 ). In addition, KT6124 was shown to exert DNAsingle strand breaks11} which was not induced by and staurosporine5) in the other intact cells,
suggesting that KT6124 could act as an inhibitor of topoisomerase I in intact cells. The last type represented by KT6006 exerted a somewhat different effect on the cell cycle (Fig. 2H) from the other compounds. This compound exhibited both S phase delay and G2Mblock with higher DNAploidy. Wehave previously shown that KT6006 but not KT6124 and KT6528 inhibits the action ofPMAin intact cells1 1} (unpublished results) as is the case for staurosporine5), K-252a11}, UCN-015) and CGP 41 251 (unpublished results). Taken together, the effect of KT6006on the cell cycle distribution may be mediated through both the inhibition of topoisomerase I and protein kinases.
In conclusion, the indolocarbazole compounds were found to exhibit diverse effects on the cell cycle progression of ras-transformed rat flbroblast cells, HR-3Y1, suggesting that there are several modes of action of these compounds on the cells. Although further analysis of the effect of each indolocarbazole compoundon the cell cycle remains to be done, cell cycle analysis using HR-3Y1 cells may be helpful for the characterization and/or prescreening of novel compoundsof this class. 
